| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Lachey Jennifer is a Chief Scientific Officer at Keros Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 21 sells.
Estimated insider holdings value: $1.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 11, 2021 | KROS Keros Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 21,200 | $59.91 | $1,270,058.05 | -7.5% | -8.7% | -22.3% | |
| Nov 4, 2021 | KROS Keros Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 10,600 | $50.00 | $530,000.00 | -11.0% | -11.8% | -8.4% | |
| Jun 11, 2021 | KROS Keros Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 2,650 | $50.98 | $135,087.22 | -1.1% | -37.5% | -43.2% | |
| May 11, 2021 | KROS Keros Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 2,650 | $50.00 | $132,500.00 | -3.6% | -31.3% | -17.1% | |
| Apr 12, 2021 | KROS Keros Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 5,300 | $60.00 | $318,026.39 | -1.8% | -28.5% | +6.9% | |
| Mar 11, 2021 | KROS Keros Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 5,300 | $64.48 | $341,749.53 | -2.8% | -19.3% | -18.8% | |
| Feb 11, 2021 | KROS Keros Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 5,300 | $64.91 | $344,016.66 | -2.9% | - | - |